Nature's Sunshine Products
American multi-level marketing company
NATR Nasdaq
SEC CIK 275053
Follow Nature's Sunshine Products
Weekly email: filings, results
Revenue, last quarter
$116.6M
−9.1% vs same quarter last year
Net income
$1.9M
−64.6% vs same quarter last year
EPS, diluted
$0.11
−63.3% vs same quarter last year
Operating cash flow
$10.8M
−41.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $480.1M | $19.5M |
| FY24 | $454.4M | $7.7M |
| FY23 | $445.3M | $15.1M |
| FY22 | $421.9M | −$390K |
| FY21 | $444.1M | $30.2M |
| FY20 | $385.2M | $23M |
| FY19 | $362.2M | $6.9M |
| FY18 | $364.8M | −$1.2M |
| FY17 | $342M | −$13.8M |
| FY16 | $341.2M | $675K |
| FY15 | $324.7M | $13.7M |
| FY14 | $366.4M | $9.8M |
| FY13 | $369.8M | $17.6M |
| FY12 | $360.8M | $25.4M |
| FY11 | $367.8M | $17.6M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 72.4% | 5.2% | 4.1% |
| FY24 | 71.5% | 4.4% | 1.7% |
| FY23 | 72.1% | 4.2% | 3.4% |
| FY22 | 71% | 3.9% | −0.1% |
| FY21 | 74% | 7.8% | 6.8% |
| FY20 | 73.7% | 5.6% | 6% |
| FY19 | 74.1% | 4.5% | 1.9% |
| FY18 | 73.8% | 1.5% | −0.3% |
| FY17 | 73.4% | 0.4% | −4% |
| FY16 | 73.3% | 2.9% | 0.2% |
| FY15 | 73.7% | 4.3% | 4.2% |
| FY14 | 75% | 5.2% | 2.7% |
| FY13 | 75% | 6.4% | 4.8% |
| FY12 | 74.7% | 9.4% | 7% |
| FY11 | 75.7% | 5.5% | 4.8% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $28.8M |
| FY24 | $14.3M |
| FY23 | $30.7M |
| FY22 | −$6.9M |
| FY21 | $27.9M |
| FY20 | $32.8M |
| FY19 | $3.4M |
| FY18 | $17M |
| FY17 | $5M |
| FY16 | −$7.6M |
| FY15 | −$12.4M |
| FY14 | −$12.1M |
| FY13 | $20.8M |
| FY12 | $20M |
| FY11 | $1.5M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | - | $16.3M |
| FY24 | - | $8.9M |
| FY23 | - | $6.4M |
| FY22 | $0 | $13.6M |
| FY21 | $19.9M | $7.4M |
| FY20 | $0 | $0 |
| FY19 | - | - |
| FY18 | $0 | - |
| FY17 | $1.8M | $0 |
| FY16 | $7.5M | $0 |
| FY15 | $7.5M | $6.6M |
| FY14 | $35.2M | $7.5M |
| FY13 | $30.4M | $2.5M |
| FY12 | $2.3M | - |
| FY11 | - | - |
- Nature's Sunshine Products
- Healthcare median
Show the numbers
| Year | Nature's Sunshine Products | Healthcare median |
|---|---|---|
| FY25 | 4.1% | −30.6% |
| FY24 | 1.7% | −47% |
| FY23 | 3.4% | −58% |
| FY22 | −0.1% | −80.4% |
| FY21 | 6.8% | −71.8% |
| FY20 | 6% | −62.2% |
| FY19 | 1.9% | −46.2% |
| FY18 | −0.3% | −49.6% |
| FY17 | −4% | −45.9% |
| FY16 | 0.2% | −36% |
| FY15 | 4.2% | −37.8% |
| FY14 | 2.7% | −35.5% |
| FY13 | 4.8% | −37.1% |
| FY12 | 7% | −29.1% |
| FY11 | 4.8% | −27.9% |